American Oncology Network, Inc. (AONC)
NASDAQ: AONC · IEX Real-Time Price · USD
5.49
-0.41 (-6.95%)
At close: Mar 28, 2024, 4:00 PM
5.45
-0.04 (-0.73%)
After-hours: Mar 28, 2024, 6:38 PM EDT

American Oncology Network Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Revenue
1,2791,150943.75724.74
Revenue Growth (YoY)
11.27%21.82%30.22%-
Cost of Revenue
1,1961,054865.79658.64
Gross Profit
82.895.4577.9666.11
Selling, General & Admin
100.7186.6177.0544.03
Other Operating Expenses
31.243.2800
Operating Expenses
131.9589.8977.0544.03
Operating Income
-49.155.570.9122.07
Interest Expense / Income
6.423.421.421.12
Other Expense / Income
7.52-0.44-0.8621.74
Pretax Income
-63.092.590.36-0.78
Income Tax
0.3800.46-0.78
Net Income
-63.472.59-0.110
Preferred Dividends
-57.932.59-0.110
Net Income Common
-5.54000
Shares Outstanding (Basic)
7888
Shares Outstanding (Diluted)
7888
Shares Change
-13.46%---
EPS (Basic)
-1.36---
EPS (Diluted)
-1.36---
Free Cash Flow
-29.7-11.89-33.9825.02
Free Cash Flow Per Share
-4.44-1.54-4.403.24
Gross Margin
6.47%8.30%8.26%9.12%
Operating Margin
-3.84%0.48%0.10%3.05%
Profit Margin
-0.43%---
Free Cash Flow Margin
-2.32%-1.03%-3.60%3.45%
Effective Tax Rate
--129.58%-
EBITDA
-39.9323.097.853.99
EBITDA Margin
-3.12%2.01%0.83%0.55%
Depreciation & Amortization
16.7417.086.083.66
EBIT
-56.676.011.770.33
EBIT Margin
-4.43%0.52%0.19%0.05%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).